Biocon settles licence agreement with Genetech for cancer treatment drug — Check earliest secured launch dates

According to Biocon’s exchange filing, the two companies executed the patent settlement agreement to resolve all pending disputes between them, including in the US, Canada and other jurisdictions.

Leave a Reply

Your email address will not be published. Required fields are marked *